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Study of healthy aging of the hypothalamic-pituitary-
thyroid axis is difficult, since aging is accompanied by the
increased frequency of various thyroid diseases and of
extrathyroidal disease, as well as by the increased intake
of medicines modulating the function of this axis. Never-
theless, researchers managed to determine that in the
paraventricular nucleus of aged humans the number of
neurons synthesizing TRH is increased. In the pituitary,
the number of thyrotrophs also increases, and the cells
are commonly hypertrophic. In the thyroid, epithelial
cells are smaller, the amount of colloid decreases, and the
whole gland becomes smaller and denser. It is still not
known how aging affects secretion of TRH. Healthy
aging is accompanied by the slight increase of concentra-
tion of TSH (highest concentrations of this hormone
were detected in centenarians), and the night peak of its
secretion is lower. In healthily aging humans, concentra-
tions of T3 and of fT3 decrease, concentration of rT3
increases, and concentrations of T4 and of fT4 remain
stable.
According to the current theory of aging, the direct
cause of aging is the accumulation of stochastic damage
to DNA, and to proteins and lipids. The most important
(albeit not only) damaging factors are the reactive
oxygen species (ROS), by-products of the cellular meta-
bolism, especially of the respiratory chain in mitochon-
dria. Most likely, the function of the hypothalamic-
pituitary-thyroid axis influences the rate of aging, since
the function of the respiratory chain and, therefore, the
rate of production of ROS, remain under the control of
T3. Consequently, slowdown of the T3-dependent meta-
bolism might promote longer life through slower pro-
duction of ROS. This hypothesis is supported by the
above described epidemiological observations showing
that healthy aging is accompanied by the decreased
activity of the hypothalamic-pituitary-thyroid axis and
by the fact that in long-lived humans (whole 85+ group
and, especially, centenarians) the activity of this axis is
lowest compared to younger age groups. Because of this,
subclinical hypothyroidism in 65 years old or older
humans might be, in fact, a manifestation of healthy
aging of the thyroid gland, and this is why in these indi-
viduals this condition should not be “automatically”
treated. Instead, the patient should be regularly exam-
ined (if we do not want to omit the overt hypothyroid-
ism), and decision to treat should be taken individually,
based on the biological age, the clinical state, the pre-
sence of other diseases, the results of biochemical tests,
etc.
The percentage of aged humans with anti-TPO and
anti-TG auto-antibodies is much higher compared to
young individuals, but above the age of 80 the percentage
of such individuals decreases. Aging is accompanied by
the increased frequency of hypothyroidism, hyperthyroid-
ism, and of thyroid cancers. Their symptoms are com-
monly untypical and, because of this, might be confused
with signs of aging per se or with symptoms of other dis-
eases. Nevertheless, all these diseases should be adequately
diagnosed and treated.
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